Table 5.
Availability of malaria commodities in the private sector
| Private For-Profit Facility | Registered pharmacy | Unregistered pharmacy | General retailer | Total private sector | |
|---|---|---|---|---|---|
| % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
| Availability of anti-malarials among all screened outlets | N = 360 | N = 145 | N = 493 | N = 14,204 | N = 15,202 |
| Any anti-malarial | 76.4 | 93.3 | 87.2 | 2.4 | 7.1 |
| (70.4, 81.4) | (87.8, 96.5) | (82.8, 90.6) | (1.7, 3.5) | (6.4, 7.9) | |
| Availability of anti-malarials among anti-malarial-stocking outlets | N = 280 | N = 134 | N = 428 | N = 244 | N = 1086 |
| QAACT | 59.3 | 73.2 | 64.3 | 9.9 | 46.7 |
| (51.2, 67.0) | (65.6, 79.7) | (58.6, 69.7) | (5.1, 18.4) | (39.4, 54.1) | |
| Non-QAACT | 52.3 | 76.8 | 48.5 | 3.0 | 37.9 |
| (44.6, 59.9) | (68.7, 83.3) | (41.4, 55.6) | (1.3, 6.8) | (31.5, 44.7) | |
| SP | 25.6 | 49.9 | 55.2 | 85.2 | 57.6 |
| (19.5, 32.9) | (38.9, 61.0) | (47.1, 63.0) | (75.1, 91.6) | (50.8, 64.0) | |
| Any non-artemisinin therapy | 50.3 | 57.2 | 68.7 | 88.5 | 69.6 |
| (42.8, 57.8) | (45.1, 68.4) | (60.6, 75.8) | (78.9, 94.1) | (63.2, 75.4) | |
| Artesunate injection | 10.1 | 1.7 | 1.2 | 0.0 | 2.9 |
| (5.9, 16.8) | (0.5, 5.6) | (0.5, 2.6) | – | (1.7, 4.7) | |
| Availability of blood testing among anti-malarial-stocking outletsa | N = 307 | N = 138 | N = 467 | N = 310 | N = 1222 |
| Any diagnostic test | 66.9 | 22.4 | 12.1 | 0.2 | 20.8 |
| (59.2, 73.8) | (16.4, 29.8) | (9.1, 16.0) | (0.0, 1.4) | (16.5, 25.8) | |
| Malaria microscopy | 48.1 | 8.8 | 3.2 | 0.0 | 12.4 |
| (39.1, 57.3) | (5.0, 15.1) | (2.0, 5.3) | – | (9.1, 16.7) | |
| RDT | 36.0 | 16.0 | 9.5 | 0.2 | 12.6 |
| (30.2, 42.3) | (11.1, 22.5) | (7.0, 13.0) | (0.0, 1.4) | (10.0, 15.8) |
Among outlets stocking anti-malarials todays or within the past 3 months